Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Mallinckrodt
AstraZeneca
McKinsey
Harvard Business School

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Litigation Details for Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution Inc. (D. Del. 2015)


Email this page to a colleague

« Back to Dashboard

Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution Inc. (D. Del. 2015)

Docket ⤷  Free Forever Trial Date Filed 2015-02-18
Court District Court, D. Delaware Date Terminated 2019-12-04
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Plaintiff Referred To
Parties INO THERAPEUTICS LLC
Patents 8,282,966; 8,291,904; 8,293,284; 8,431,163; 8,573,209; 8,573,210; 8,776,794; 8,776,795; 8,795,741; 8,846,112; 9,265,911; 9,279,794; 9,295,802
Attorneys Caroline Lourgos
Firms Wilks, Lukoff & Bracegirdle, LLC
Link to Docket External link to docket
Small Molecule Drugs cited in Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-02-18 1 23, 1999. THE PATENTS-IN-SUIT 13. United States Patent No. 8,282,966 (the “’966 patent,” copy attached…ANDA Product. COUNT I INFRINGEMENT OF U.S. PATENT NO. 8,282,966 39. Plaintiffs repeat and reallege paragraphs…’966 patent, the ’284 patent, the ’163 patent, the ’741 patent, the ’112 patent, the ’904 patent, the …’966 patent, the ’284 patent, the ’163 patent, the ’741 patent, the ’112 patent, the ’904 patent, the …’966 patent, the ’284 patent, the ’163 patent, the ’741 patent, the ’112 patent, the ’904 patent, the External link to document
2016-07-05 131 ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 8,282,966, 8,293,284, 8,431,163, 8,795,741, 8,846,…2015 5 December 2019 1:15-cv-00170 830 Patent Plaintiff District Court, D. Delaware External link to document
2016-07-13 138 Decision in Inter Partes Review of U.S. Patent No. 8,846,112 B2 by Praxair Distribution Inc., Praxair…2015 5 December 2019 1:15-cv-00170 830 Patent Plaintiff District Court, D. Delaware External link to document
2016-08-02 156 alleging infringement of U.S. Patent Nos. 8,282,966 ("the '966 patent"); 8,293,284 ("…#x27;802 patent, '911 patent, and '794 patent (collectively, "the new patents") issued… patent"); 8,776,794 ("the '794 patent"); 8,573,209 ("the '209 patent"…continuation of U.S. Patent No. 8,573,209, one of the patents-in-suit, and the '802 patent is a continuation…addition of the new patents. First, the new patents bear close relation to the asserted patents: the '911 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Dow
Mallinckrodt
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.